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  34 
ABSTRACT 35 
 36 
Two series of potentially tridentate ligands of formula ArCH=N(CH2)2NMe2 and 37 
ArCH=N(CH2)3NMe2 (Ar = C6H5, 2-FC6H4, 4-FC6H4, 2,3,4-F3C6H2) were used to prepare 38 
[C,N,N′]-cyclometalated platinum compounds containing either a chloro or a methyl ancillary ligand. 39 
The synthesis of the compounds [PtCl{Me2N(CH2)xN=CHR}] (3a−h), via the corresponding 40 
compounds [PtCl2{Me2N(CH2)xN=CHAr}] (2), requires drastic conditions and proceeds more easily 41 
for ligands derived from N,N-dimethylpropylenediamine (x = 3). Along the process, an unexpected 42 
selective nucleophilic substitution of a fluoro for a methoxy substituent took place at the aryl ring for 43 
ligands 2,3,4-F3C6H2CH=N(CH2)xNMe2. The syntheses of compounds 44 
[PtMe{Me2N(CH2)xN=CHR}] (4a−h) using [Pt2Me4(μ-SMe2)2] as a precursor took place for all 45 
ligands under relatively mild conditions. All compounds were fully characterized, including molecular 46 
structure determination for [PtCl{Me2N(CH2)3N=CH(4-FC6H3)}] (3b) and [PtCl{Me2N-47 
(CH2)3N=CH(2-OMe,3,4-F2C6H)}] (3g). The absorption and emission spectra were also studied for the 48 
[C,N,N′]-cyclometalated platinum(II) compounds, and all of the compounds were emissive in the solid 49 
state and in dichloromethane solution at room temperature (compounds 3) or at 77 K (compounds 4). 50 
The size of the [N,N′]-chelate ring and the number and position of the substituents in the aryl ring 51 




  56 
INTRODUCTION 57 
 58 
In the last years significant research effort has focused on the photophysical properties of luminescent 59 
square-planar platinum complexes. The aim of this research is to provide an understanding of the factors 60 
that govern the luminescence efficiencies of platinum(II) complexes as well as to apply these 61 
compounds in organic light emitting diodes (OLEDs) and in other devices.1 62 
Many cyclometalated platinum complexes have proved to be luminescent in solution at ambient 63 
temperature, because [C,N] ligands increase the energies of metal-centered excited states in comparison 64 
to analogous [N,N] ligands.1 In addition, rigidity generally favors luminescence over nonradiative decay 65 
pathways, and therefore tridentate [N,N,C], [N,C,N], and [C,N,C] ligands generally based on substituted 66 
pyridines and polypyridines may offer an advantage over bidentate [C,N] ligands.2 Moreover, 67 
systematic studies carried out for several of these systems indicate that the emission may be tuned by 68 
structural modification of the ligands; in particular, the nature and the position of the substituents might 69 
influence the photophysics of the platinum complexes.1,3 70 
In spite of the great number of cycloplatinated compounds for which the luminescence properties have 71 
been studied so far, those containing aldimine or ketimine ligands have been less explored.4 In this work 72 
we report the preparation and luminescence properties of cyclometalated platinum compounds 73 
containing tridentate [C,N,N′] imine ligands with fluoro substituents (compounds 3 and 4 shown in 74 
Chart 1). This study should allow us to compare the behavior of these compounds in relation with (a) the 75 
size of the [N,N′] chelate ring (five- versus six-membered), (b) the number and position of the fluoro 76 
substituents in the ring, and (c) the nature of the ancillary ligands (methyl or chloro) coordinated to the 77 
platinum. These effects will also be analyzed in relation to the choice and success of the preparation 78 
procedure. 79 
. 80 
  81 
RESULTS AND DISCUSSION 82 
 83 
Two series of potentially tridentate ligands of formula ArCH=N(CH2)2NMe2 and 84 
ArCH=N(CH2)3NMe2 (Ar = C6H5, 2-FC6H4, 4-FC6H4, 2,3,4-F3C6H2) derived from N,N-85 
dimethylethylenediamine and N,N-dimethylpropylenediamine, respectively, were used in the present 86 
work. As stated above, the ligands were selected in order to compare the results between those derived 87 
from propylene or ethylenediamine, as well as to analyze the effect of fluorine substituents. In particular, 88 
the position of a single fluoro substituent in an ortho or para position as well as the increased 89 
fluorination will be studied. 90 
Synthesis of Compounds [PtCl{Me2N(CH2)xN=CHR}](3a−h). The syntheses of compounds 91 
[PtCl{Me2N(CH2)3N=CHC6H5}] (3e)5 and [PtCl{Me2N(CH2)2N=CHC6H5}] (3f)6 have been 92 
previously reported from the corresponding ligands, cis-[PtCl2(dmso)2] as metalating agent, methanol 93 
as solvent, and sodium acetate as an external base. However, a systematic comparison of the reactivities 94 
of both series of ligands containing either an ethylene or a propylene moiety linking the two nitrogen 95 
atoms and different substituents in the aryl ring has not been carried out so far. With this purpose, in this 96 
work we planned to follow the general synthetic procedure shown in Scheme 1 for both series of imines. 97 
Initially, several reaction conditions were tested for ligand 1a, including either one-pot procedures or 98 
prior isolation of the corresponding [N,N′]-chelate complex 2a. As previously reported for similar 99 
systems,5−7 the best results were obtained when [N,N′] coordination compounds (compounds 2) were 100 
previously isolated and such complexes, when refluxed for several hours in a donor solvent in the 101 
presence of sodium acetate, further reacted to yield cycloplatinated derivatives via C−H activation. The 102 
best results for the latter step were obtained when an equivalent amount of sodium acetate was used and 103 
the reaction time in refluxing methanol was 48−72 h, since the use of larger amounts of added base, 104 
prolonged reaction times, or the use of mixtures of toluene and methanol as solvents led to partial 105 
decomposition with formation of metallic platinum. Therefore, these optimal reaction conditions were 106 
followed in the synthesis of compounds 3, which requires previous isolation of the corresponding 107 
compounds 2. 108 
The reaction of the imines 1a−g with cis-[PtCl2(dmso)2] in refluxing methanol gave the corresponding 109 
coordination compounds [PtCl2{Me2N(CH2)xN=CHAr}] (2). For ligands derived from N,N-110 
dimethylpropanediamine a mixture of two isomers corresponding to the two possible conformations (Z 111 
and E) around the C=N bond was obtained. Generally, the Z isomer was the most abundant, or even the 112 
only one which was isolated and characterized, as for 2b. However, for ligands derived from N,N-113 
dimethylethylenediamine, the corresponding coordination compounds were isolated exclusively as the 114 
less sterically crowded E isomer. The different behavior might arise from the higher flexibility of the 115 
six- versus the five-membered [N,N′]-chelate rings, which minimizes the steric crowding around the 116 
platinum in the Z isomer. As previously reported,5,8 these isomers display striking differences in their 117 
spectral features. In particular, the imine proton of the E isomers is strongly deshielded (δ ca. 9.30−9.60 118 
ppm) due to the proximity to platinum and displays lower J(H−Pt) values (48−60 Hz) in comparison to 119 
those for the Z isomers (115−120 Hz). In addition, for the Z isomer both the methylene and NMe2 120 
protons are nonequivalent. The number of signals observed in the 19F NMR spectra was in all cases 121 
consistent with the presence of one or two isomers, as well as with the number of fluorine substituents in 122 
the imine. Formation of the [N,N′]-chelate compounds [PtCl{Me2N(CH2)xN=CHAr}] (2) was 123 
confirmed by ESI(+) mass spectra and elemental analyses. 124 
The tridentate [C,N,N′] cyclometalated compounds 3a−d were obtained from the equimolar reaction of 125 
the coordination compounds and sodium acetate in refluxing methanol. The process involves the 126 
activation of a C(aryl)−H bond and the formal release of HCl, which is promoted in the presence of a 127 
base. For compounds 2c,d, the C−H bond activation should be preceded by an isomerization step from 128 
an unreactive E to the adequate Z conformation. In contrast, compounds 2a,b, containing the more 129 
flexible propylene moiety, were obtained as a mixture of Z and E conformers (2a) or as the Z conformer 130 
exclusively (2b), thus facilitating the cyclometalation process. The yields of the cyclometalation 131 
reactions were in all cases moderate; however, slightly higher yields in the range 36−40% were obtained 132 
for propylene derivatives 3a,b after 48 h in comparison to those for the corresponding ethylene 133 
derivatives 3c,d, for which yields in the range 29−32% were obtained after 72 h. These results confirm 134 
that the higher flexibility of the propylene versus the ethylene moieties facilitates the cyclometalation 135 
reaction, leading to [C,N,N′]-cycloplatinated compounds. In all cases, 1H NMR spectra confirmed the 136 
formation of the expected fused [6,5,6]- or [6,5,5]-tricyclic system. As reported for analogous 137 
systems,5,6,8 J(H−Pt) values for the imine proton (141−144 Hz) are higher than those observed for 138 
compounds 2. The 19F NMR spectra show only one signal, for which coupling to platinum was only 139 
observed for compound 3a. For 3b, 13C NMR and 1H−13C-HSQC spectra were also taken and confirm 140 
the cyclometalation process, since only three resonances corresponding to aromatic C−H were observed. 141 
All compounds were characterized by ESI(+) mass spectra and elemental analyses, and 3b was also 142 
characterized crystallographically. 143 
With the aim of obtaining the corresponding tridentate [C,N,N′]-cyclometalated compounds the 144 
reactions of the coordination compounds 2g,h with an equimolar amount of sodium acetate in refluxing 145 
methanol were also carried out. However, for these ligands the reaction (shown in Scheme 2) was more 146 
complex and involved a selective nucleophilic substitution of the fluorine substituent adjacent to the 147 
imine group for a methoxy group, leading eventually to the compounds [PtCl{Me2N(CH2)xN=CH(2-148 
OMe,3,4-F2C6H)}] (3g for x = 3 and 3h for x = 2). Selective platinum-catalyzed activation and 149 
subsequent functionalization of aryl C−F bonds to produce arylmethyl ethers in a process involving 150 
platinum(IV)/platinum(II) species has been reported. 9 The involvement of platinum(IV) species is ruled 151 
out in the present case, since previous results indicate that intramolecular C−F bond activation takes 152 
place at electron-rich platinum substrates such as [Pt2Me4(μ-SMe2)2] but not at cis- [PtCl2(dmso)2].10 153 
On the other hand, ligands 1g,h were recovered unaltered after 72 h of reflux in methanol in the presence 154 
of an equimolar amount of sodium acetate. Moreover, the fluoro for methoxy substitution was not 155 
observed along the syntheses of compounds 3a−d, for which only one fluoro substituent is present. 156 
Therefore, it is likely that the combined effects of coordination of the imine ligand to platinum and the 157 
presence of several fluorine substituents are able to activate the fluoroaryl group toward nucleophilic 158 
aromatic substitution in a way similar to that for recently reported examples in which acetylenes are 159 
used as electron-withdrawing groups promoting nucleophilic aromatic substitution.11 The presence of 160 
sodium acetate in the reaction media is also required, since the fluoro for methoxy substitution process 161 
was not observed in the preparation of compounds 2g,h. It is interesting to point out that fluorine for 162 
alkoxy nucleophilic substitution has been reported as a strategy leading to blue-emitting cyclometalated 163 
iridium(III) complexes with increased solubility.12  164 
In both cases, the 1H NMR spectra confirmed formation of the [C,N,N′]-cycloplatinated compounds and 165 
the J(H−Pt) values for the imine proton are similar to those obtained for compounds 3a−d. Only one 166 
resonance corresponding to an aromatic proton was observed, and a doublet at ca. 4 ppm was assigned 167 
to the methoxy hydrogen atoms which are coupled to the adjacent fluorine. The 19F NMR spectra show 168 
only two signals, whose multiplicities and coupling constants are in good agreement with the proposed 169 
structures.13 The characterization of these compounds was completed with ESI(+) mass spectra, 170 
elemental analyses, and the determination of the molecular structure of 3g. 171 
Crystal Structures of Compounds 3b,g. Suitable crystals of compounds 3b,g (Figures 1 and 2, 172 
respectively) were grown from dichloromethane−methanol solution. For 3b, the asymmetric unit 173 
contains eight molecules (Figures S1 and S2, Supporting Information) that are spaced between 5 and 8 174 
Å: i.e., the distances are too long to be able to establish weak intermolecular interactions. The crystal 175 
structure of 3g is constituted by two different molecules distributed in antiparallel positions (Figure S3, 176 
Supporting Information) which are connected by H bonds between the O atom of the methoxy units and 177 
one hydrogen atom of the central methylene of the diamine of a second molecule. The 3D packing of the 178 
complex is constituted by different dimers, as shown in the unit cell (Figure S4, Supporting 179 
Information). 180 
The compounds consist of a fused [6,5,6]-tricyclic system containing an ortho-metalated phenyl group, a 181 
five-membered metallacycle and a six-membered chelate ring with two nitrogen atoms coordinated to 182 
platinum. The square-planar coordination around the platinum is completed with a chlorine atom. For 183 
3g, the molecular structure provides conclusive evidence of the presence of a methoxy group in the 184 
position adjacent to the imine moiety, as deduced from NMR spectra. Bond lengths and angles are well 185 
within the range of values obtained for analogous compounds.5−8 The Pt−amine distances are greater 186 
than Pt−imine distances in agreement with both the weaker ligating ability of amines for platinum and 187 
the greater trans influence of the aryl versus the chloro ligand.8c Most bond angles at platinum are close 188 
to the ideal value of 90°, and the smallest angle corresponds in each case to the metallacycle (80.3(4)° 189 
(3b) and 80.76(15)° (3g)). As previously observed for related compounds,5 the six-membered chelate 190 
ring presents a strong deviation from planarity and the chelate angles N(1)−Pt−N(2) (97.2(4)° (3b) and 191 
96.78(13)° (3g)) are in both cases greater than for analogous compounds with a fivemembered chelate 192 
ring. In each case, the metallacycle is nearly coplanar with the coordination plane, the dihedral angle 193 
between the mean planes being 2.3(4)° for 3b and 3.22(15)° for 3g. 194 
Synthesis of Compounds [PtMe{Me2N(CH2)xNCH=R}](4a−h). The synthesis of compounds 195 
[PtMe{Me2N-(CH2)xN=CHR}] (4a−h) was carried out following the previously reported procedures 196 
for compounds 4c,f,h, which consist of the reaction of [Pt2Me4(μ-SMe2)2] with the corresponding 197 
imine.14 The mechanism of these reactions has been thoroughly studied, and it is assumed that prior 198 
coordination of the ligand produces [N,N′]-chelate complexes that further react to produce 199 
cyclometalated compounds with loss of methane.14 These compounds have been generally prepared 200 
under mild conditions, for instance in acetone at room temperature, and the bidentate imines used so far 201 
are derived from N,N-dimethylethylenediamines. In this work, as shown in Scheme 3, the reactions 202 
were carried out in refluxing toluene and were completed within 1 h for both imines derived from 203 
ethylene and propylenediamines. In this case, no further reaction was observed for the trifluorinated 204 
imines 1g,h, which can be related to the greater electron density of the platinum in these compounds, as 205 
well as to the absence of methanol in the reaction mixtures. As a whole, this method appear to be a 206 
convenient one-pot procedure that does not require previous isolation of the corresponding coordination 207 
compounds to give the cyclometalated compounds with good yields. In all cases, 1H NMR spectra 208 
confirmed formation of the expected [C,N,N′] cycloplatinated compounds, in which a methyl ligand 209 
completes the coordination sphere around the platinum. The methyl ligand, the imine, and the NMe2 are 210 
coupled to platinum, and the J(H−Pt) values for the imine proton (ca. 60 Hz) are lower than those 211 
obtained for compounds 3, which is consistent with the presence of a methyl instead of a chloro ligand 212 
trans to the imine.8a,b The 19F NMR spectra are consistent with the proposed structures: in particular, 213 
the presence of three signals for 4g,h confirms the presence of the three fluoro atoms. 214 
Absorption and Emission Spectroscopy. Both absorption and emission spectra have been recorded in 215 
aerated dichloromethane solutions, and emission spectra were also recorded in the solid state for 216 
cyclometalated platinum compounds 3 and 4. The resulting data are shown in Table 1 with 217 
representative absorption and emission spectra shown in Figures 3−6. 218 
The absorption spectra of 10−4 M dichloromethane solution of compounds 3 in solution at 298 K show 219 
several bands in the UV−visible range with moderate ε values. The lowest energy band in the range 220 
376−400 nm with extinction coefficients between 2200 and 5100 M−1 cm−1 is attributable to Pt(5d) →221 
π*(L) metal-to-ligand charge transfer (MLCT) mixed with intraligand (IL) transitions.15 Compounds 3 222 
emit in the visible region at 298 K when excited at the wavelength corresponding in each case to the 223 
lowest energy band. The emission spectra of all compounds 3 follow a similar pattern and display three 224 
maxima (one displayed as shoulder) in the range 575−700 nm. The observation of vibronically 225 
structured bands with progressional spacings at ca. 1200 cm−1, typical of ν(C=C) and ν(C=N) stretching 226 
frequencies in the excited state, demonstrates the involvement of ligand character in their emission 227 
origin. Solid emission spectra were also recorded upon excitation of the samples at the corresponding 228 
lowest energy absorption band. In all cases, the same profile (well vibronically structured band) as 229 
recorded in solution is observed (Table 1 and Figures S5 and S6 (Supporting Information)). No 230 
excimeric emission bands that usually present broad emission bands were recorded in any case. 231 
Emission spectra were also recorded at different concentrations in order to check if possible aggregate 232 
formation was obtained in solution. As can be seen in Figure S8 (Supporting Information), the emission 233 
profile when going from 1 × 10−4 to 3 × 10−5 M is similar and the contribution of aggregates on the 234 
spectra does not seem to be very certain. Nevertheless, it cannot be ruled out definitively, due to the 235 
small increase of the longer wavelength emission at higher concentrations. This is in agreement with the 236 
fact that no π−π stacking interactions are observed in the crystal packing of the molecules (Figures 237 
S1−S4, Supporting Information). 238 
In all cases, the excitation spectra match the absorption spectra in solution at room temperature. The 239 
large red shift observed for the emission is characteristic of phosphorescence emission, as expected from 240 
a triplet state typical for platinum complexes due to strong spin−orbit coupling favored by the well-241 
known heavy-atom effect. This is in agreement with the high luminescence lifetime values estimated on 242 
the order of 1 μs when we record the spectra of the complexes in the presence and in the absence of 243 
oxygen. 244 
Although the differences in emission energies are very small, it was found that the presence of a fluoro 245 
substituent in position 2 produces a small red shift (ca. 5 nm) and a blue shift (10−15 nm) for the 246 
substituent in position 4 for both series of compounds derived from ethylenediamine (3f,c,d) or from 247 
propylenediamine (3e,a,b). The apparently controversial effect of fluoro substituents can be rationalized 248 
by taking into account the inductive electron-withdrawing and the mesomeric electron-donating effects 249 
of fluorine, which might result in an decreased or an increased electron density on platinum.3 250 
Compounds 3g,h, which contain a methoxy group at the 2-position together with fluoro substituents at 251 
the 3- and 4- positions, also display a small red shift in comparison with the unsubstituted analogues 252 
3e,f. Similar effects in the emission wavelengths due to the presence of fluoro or methoxy substituents 253 
have been previously reported.3,16 254 
The calculated quantum yields are modest (ca. 10−3) and are in agreement with the fact that the 255 
strongest emission is recorded for 3d. For each pair of compounds with the same substituents, the 256 
emission is more intense for the compounds derived from ethylenediamine than for those derived from 257 
propylenediamine (3c > 3a, 3d > 3b, 3f > 3e, and 3h > 3g). Although the differences are small, this trend 258 
is consistent with the fact that the greater rigidity associated with the five- versus the six-membered 259 
chelates favors luminescence over nonradiative decay pathways. Attempts to improve the photophysical 260 
properties by modifying the [N,C,N] ligand, in particular the size of the chelate rings, have been recently 261 
reported.17 262 
Studies carried out for compounds 4 indicate absorption spectra similar to those obtained for compounds 263 
3, with the lowest energy band in the range 391−415 nm. The lower energy of these bands in 264 
comparison to those of compounds 3 (in the range 376−400 nm) can be related to the higher electron 265 
density at the metal center expected for compounds 4. Compounds 4, when excited at the lowest energy 266 
absorption band were nearly nonemissive in solution at room temperature. This could be due to the 267 
presence of a high-energy oscillator (C−H) in their first coordination sphere, which could provide an 268 
efficient pathway for multiphonon relaxation. On the other hand, at 77 K deactivation processes are 269 
minimized and emission was observed. The obtained spectra were similar to those corresponding to 270 
compounds 3. In particular, for both series of ligands derived from either ethylene or propylenediamine, 271 
a small red shift is observed when a fluoro substituent is present in position 2 (4c versus 4f or 4a versus 272 
4e), while the presence of a fluoro substituent in position 4 produces a small blue shift (4d versus 4f or 273 
4b versus 4e). The most strongly emissive compound of this series is 4b, as shown in Figure 6, where 274 
the emission spectra of the complexes are normalized with respect to 4b. 275 
Finally, a comparison of compounds 3 and 4 which only differ in the ancillary ligand (chloro versus 276 
methyl) suggests that the chloro derivatives are best suited for photophysical properties, since they are 277 
luminescent in solution at room temperature while methyl analogues only display this behaviour at low 278 
temperature. This result supports the fact that the identity of the remaining ligand in tridentate 279 
cycloplatinated compounds is also crucial in determining whether or not the compounds are emissive.1b 280 
Although C-donor ligands such as cyanide and acetylide which are able to increase the ligand field 281 
strength have been shown to give good results,1b the methyl ligand is not such a good choice since, as 282 
stated above, it can provide an efficient pathway for multiphonon relaxation.  283 
 284 
 285 
  286 
CONCLUSIONS 287 
 288 
The cyclometalated compounds [PtMe{Me2N(CH2)xN=CHR}] (4a−h) with R = C6H4, 2-FC6H3, 4-289 
FC6H3, 2,3,4-F3C6H were easily obtained from the reaction of [Pt2Me4(μ-SMe2)2] with the 290 
corresponding ligands derived from either N,N-dimethylpropylene or N,N-dimethylethylenediamine. In 291 
contrast, the synthesis of the corresponding chloro analogues [PtCl{Me2N(CH2)xN=CHR}] (3a−h), 292 
carried out from the corresponding precursors [PtCl2{Me2N(CH2)xN=CHAr}] (2), was found to be 293 
more favored for six-membered than for five-membered [N,N′]-chelates. This result is related to the fact 294 
that for the latter the bidentate ligand adopts the E conformation and consequently an E−Z isomerization 295 
should precede the cyclometalation step. In addition, for the ligands 2,3,4-F3C6H2CHN(CH2)xNMe2 296 
an unexpected nucleophilic substitution of a fluoro for a methoxy substituent took place along the 297 
cyclometalation process, leading to the compounds [PtCl{Me2N(CH2)xN=CH(2-OMe,3,4-F2C6H)}] 298 
(3g for x = 3 and 3h for x = 2). Further work aimed at analyzing the scope of this process is currently in 299 
progress. 300 
Cycloplatinated compounds 3a−g are luminescent in the solid state and in solution at room temperature, 301 
and those containing a [6,5,5]-tricyclic system display higher quantum yields in comparison to those 302 
containing a [6,5,6]-tricyclic system. Cycloplatinated compounds 4a−g are luminescent in the solid state 303 
and in solution at low temperature. For both series of cyclometalated platinum compounds, the emission 304 
energies can be tuned by varying the aryl substituents. 305 
 306 
  307 
EXPERIMENTAL SECTION 308 
 309 
General Considerations. Microanalyses were performed at the Centres Cientifí cs i Tecnolog̀ ics 310 
(Universitat de Barcelona).18 Mass spectra were performed at the Unitat d’Espectrometria de Masses 311 
(Universitat de Barcelona) in a LC/MSD-TOF spectrometer using 1/1 H2O/CH3CN to introduce the 312 
sample (ESI-MS) or in a ThermoFinnigan TRACE DSQ spectrometer (CI-MS). NMR spectra were 313 
performed at the Unitat de RMN d’Alt Camp de la Universitat de Barcelona using a Mercury-400 (1H, 314 
400 MHz; 1H−13C HSQC; 13C, 100.6 MHz; 19F, 376.5 MHz) spectrometer and referenced to SiMe4 315 
(1H, 13C) or CFCl3 (19F). δ values are given in ppm and J values in Hz. Abbreviations used: s, singlet; 316 
d, doublet; t, triplet; q, quadruplet; qi, quintuplet; m, multiplet; br, broad. UV−visible spectra of CH2Cl2 317 
solutions of compounds 1, 3, and 4 were recorded at 298 K with a Cary 100 scan 388 Varian UV 318 
spectrometer, and the emission and excitation spectra of aerated solutions of compounds 3a−h and 4a−h 319 
were obtained on a Horiba Jobin-Yvon SPEX Nanolog-TM spectrofluorimeter at 298 K or at 77 K. 320 
Deoxygenated solutions of the compounds have been also used for the estimation of luminescence 321 
lifetimes. This experiments have been done bubbling N2(g) previously saturated with dichloromethane 322 
in order to minimize the concentration of the sample. Total luminescence quantum yields were measured 323 
at 298 K relative to [Ru(bipy)3]Cl2 in water (ϕ = 0.042) as a standard reference.19 The corresponding 324 
absorption of the complexes used for these measurements is lower than 0.1. 325 




Preparation of the Complexes. The compounds cis-[PtCl2(dmso)2]20 and [Pt2Me4(μ-SMe2)2],21 330 
ligands 1c,f,h13 and 1e,5 and compounds 2e and 3e,5 2f and 3f,6 and 4c,f,h14 were prepared as reported 331 
elsewhere. 332 
2-FC6H4CHN(CH2)3NMe2 (1a). This compound was obtained from the reaction of 0.500 g (4.9 333 
mmol) of 3-dimethylamino-1-propanamine with 0.610 g (4.9 mmol) of 2-fluorobenzaldehyde in 20 mL 334 
of toluene. The reaction mixture was stirred at room temperature for 2 h, sodium sulfate was added and 335 
filtered off, and the solvent was removed under vacuum to give a yellow oil. Yield: 0.969 g (95%). 1H 336 
NMR (400 MHz, CDCl3): δ 8.25 [s, 1H, CHN]; 7.96 [dd, 1H, 3J(H−H) = 2.0, 3J(H−H) = 7.6, H6]; 7.38 337 
[m, 1H, H5]; 7.17 [t, 1H, 3J(H−H) = 7.6, H4]; 7.07 [ddd, 1H, 4J(H−H) = 1.2, 3J(H−H) = 8.4, 3J(F−H) = 338 
10.4, H3]; 3.68 [td, 2H, 4J(H−H) = 1.6, 3J(H−H) = 7.2, NCH2]; 2.37 [t, 2H, 3J(H−H) = 7.2, 339 
CH2NMe2]; 2.26 [s, 6H, NMe2]; 1.89 [qi, 2H, 3J(H−H) = 7.0, CH2CH2CH2]. 19F NMR (376,5 MHz, 340 
CDCl3): δ −122.09 [m, 1F]. CI-MS: 208.9 [M + H]+ .  341 
4-FC6H4CH=N(CH2)3NMe2 (1b). This compound was prepared as a yellow oil by following the same 342 
method from 0.510 g (5.0 mmol) of 3-dimethylamino-1-propanamine and 0.620 g (5.0 mmol) of 4-343 
fluorobenzaldehyde. Yield: 0.912 g (88%). 1H NMR (400 MHz, CDCl3): δ 8.25 [s, 1H, CHN]; 7.72 [m, 344 
2H, H2,6]; 7.09 [dd, 2H, 4J(H−H) = 2.4, 3J(F−H) = 8.8, H3, 5]; 3.63 [td, 2H, 4J(H−H) = 1.2, 3J(H−H) = 345 
7.2, NCH2]; 2.36 [t, 2H, 3J(H−H) = 7.2, CH2NMe2]; 2.24 [s, 6H, NMe2]; 1.87 [qi, 2H, 3J(H−H) = 7.2, 346 
CH2CH2CH2]. 19F NMR (376.5 MHz, CDCl3): δ −109.92 [m, 1F]. CI-MS: 208.9 [M + H]+. 347 
4-FC6H4CH=N(CH2)2NMe2 (1d). This compound was prepared as a pale yellow oil by following the 348 
same method from 0.580 g (6.3 mmol) of 2-dimethylamino-1-ethanamine and 0.880 g (7.1 mmol) of 4-349 
fluorobenzaldehyde. Yield: 1.119 g (92%). 1H NMR (400 MHz, CDCl3): δ 8.26 [s, 1H, CHN]; 7.71 350 
[dd, 2H, 4J(F−H) = 5.6, 3J(H−H) = 8.8, H2,6]; 7.06 [t, 2H, 3J(H−F) = 3J(H−H) = 8.8, H3,5]; 3.71 [t, 351 
2H, 3J(H−H) = 6.8, NCH2]; 2.62 [t, 2H, 3J(H−H) = 6.8, CH2NMe2]; 2.30 [s, 6H, NMe2]. 19F NMR 352 
(376,5 MHz, CDCl3): δ −109.79 [m, 1F]. CI-MS: 194.9 [M + H]+. 353 
2,3,4-F3C6H2CH=N(CH2)3NMe2 (1g). This compound was prepared as a yellow oil following the 354 
same method from 0.638 g (6.24 mmol) of 3-dimethylamino-1-propanamine and 1.0 g (6.24 mmol) of 355 
2,3,4-trifluorobenzaldehyde. Yield: 0.838 g (55%). 1H NMR (400 MHz, CDCl3): δ 8.49 [s, 1H, CHN]; 356 
7.71 [dd, 1H, 3J(H−H) = 8.0, 4J(H−F) = 4.0, H6]; 7.01 [m, 1H, H5]; 3.67 [t, 2H, 3J(H−H) = 6.8, 357 
NCH2]; 2.34 [t, 2H, 3J(H−H) = 7.2, CH2NMe2]; 2.24 [s, 6H, NMe2]; 1.86 [qi, 2H, 3J (H−H) = 7.2, 358 
CH2CH2CH2]. 19F NMR (376,5 MHz, CDCl3): δ −131.08 [m, F2]; - 143.07 [dtd, 3J(F−F) = 18.8, 359 
4J(F−F) = 3J(H−F) = 7.5, 4J(F−H) = 3.8, F4]; −160.90 [tdd, 3J(F−F) = 18.8, 4J(F−H) = 7.5, 5J(F−H) = 360 
2.2, F3]. CI-MS: 244.7 [M + H]+. 361 
[PtCl2{Me2N(CH2)3N=CH(2-FC6H4)}] (2a). A mixture formed by 0.303 g (0.72 mmol) of cis-362 
[PtCl2(dmso)2] and 0.153 g (0.73 mmol) of imine 1a was treated with dry methanol and heated at 65 °C 363 
for 4 h with continuous stirring. The mixture was filtered; the solvent was evaporated to half volume, 364 
allowing crystallization at room temperature. Yield (white solid; mixture of E and Z isomers): 0.223 g 365 
(65%). 1H NMR (400 MHz, CDCl3): Z isomer δ 10.96 [t, 1H, 3J(H−H) = 8.0, H6]; 8.89 [s, 1H, 366 
3J(Pt−H) = 118.4, CHN]; 7.68 [m, 1H, H4]; 7.46 [t, 1H, 3J(H−H) = 8.0, H5]; {5.00 [m, 1H]; 4.21 [m, 367 
1H], CH2N}; 3.20 [m, 1H, CH2NMe2]; {2.99 [s, 3H]; 2.86 [s, 3H], NMe2}; {2.41 [m, 1H]; 1.97 [m, 368 
1H], CH2CH2CH2}. 1H NMR (400 MHz, CDCl3): E isomer δ 9.35 [s, 1H, 3J(Pt−H) = 60.0, CHN]; 369 
7.56 [m, 1H, H4]; 7.37 [t, 1H, 3J(H−H) = 7.2, H5]; 4.02 [t, 2H, 3J(H−H) = 6.8, CH2N]; 3.01 [s, 6H, 370 
NMe2]; 2.72 [m, 2H, CH2NMe2]; 2.21 [m, 2H, CH2CH2CH2]. 19F NMR (376.5 MHz, CDCl3): δ 371 
−110.7 [m, Z isomer]; − 115.75 [m, E isomer]. ESI (+)-MS: 492.07 [M + NH4]+ ; 439.07 [M − Cl]+; 372 
497.03 [M + Na]+. Anal. Found (calcd for C12H17Cl2FN2Pt): C, 29.7 (30.39); H, 3.5 (3.62); N, 5.7 373 
(5.92). 374 
[PtCl2{Me2N(CH2)3N=CH(4-FC6H4)}] (2b). This compound was prepared by following the same 375 
procedure from 0.302 g (0.72 mmol) of cis-[PtCl2(dmso)2] and 0.153 g (0.73 mmol) of imine 1b. Yield 376 
(offwhite solid; Z isomer): 0.165 g (49%). 1H NMR (400 MHz, CDCl3): δ 9.34 [m, 2H, H2,6]; 8.47 [s, 377 
1H, 3J(Pt−H) = 115.6, CHN]; 7.27 [t, 2H, 3J(H−F) = 3J(H−F) = 8.0, H3,5]; {4.93 [m, 1H]; 4.13 [m, 378 
1H], CH2N}; {3.20 [m, 1H]; 2.72 [m, 1H], CH2NMe2}; {2.97 [s, 3H]; 2.84 [s, 3H], NMe2}; {2.50 [m, 379 
1H]; 1.97 [m, 1H], CH2CH2CH2}. 19F NMR (376.5 MHz, CDCl3): δ −101.64 [m]. ESI (+)-MS: 380 
492.08 [M + NH4 ]+ ; 971.01 [2 M + Na]+. Anal. Found (calcd for C12H17Cl2FN2Pt): C, 31.1 (30.39); 381 
H, 3.6 (3.62); N, 5.5 (5.92). 382 
[PtCl2{Me2N(CH2)2N=CH(2-FC6H4)}] (2c). This compound was prepared by following the same 383 
procedure from 0.301 g (0.71 mmol) of cis-[PtCl2(dmso)2] and 0.160 g (0.82 mmol) of imine 1c. Yield 384 
(yellow solid; E isomer): 0.149 g (45%). 1H NMR (400 MHz, CDCl3): δ 9.60 [s, 1H, 3J(Pt−H) = 57.6, 385 
CHN]; 7.60 [m, 1H, H4]; 7.44 [d, 1H, 3J(H−H) = 7.6, H6]; 7.30 [td, 1H, 4J(H−H) = 1.2, 3J(H−H) = 7.6, 386 
H5]; 7.19 [t, 1H, 3J(F−H) = 9.2, H3]; 3.82 [t, 2H, 3J(H−H) = 6.0, CH2N]; 3.12 [s, 6H, 3J(Pt−H) = 33.2, 387 
NMe2]; 2.67 [t, 2H, 3J(H−H) = 6.0, CH2NMe2]. 19F NMR (376.5 MHz, CDCl3): δ −108.32 [m]. ESI 388 
(+)-MS: 478.06 [M + NH4]+ ; 483.01 [M + Na]+ . Anal. Found (calcd) for C11H15Cl2FN2Pt): C 28.4 389 
(28.71); H 2.9 (3.29); N 6.3 (6.10). 390 
[PtCl2{Me2N(CH2)2N=CH(4-FC6H4)}] (2d). This compound was prepared by following the same 391 
procedure from 0.302 g (0.71 mmol) of cis-[PtCl2(dmso)2] and 0.150 g (0.82 mmol) of imine 1d. Yield 392 
(yellow solid; E isomer): 0.131 g (43%). 1H NMR (400 MHz, CDCl3): δ 9.47 [s, 1H, 3J(Pt−H) = 54.4, 393 
CHN]; 7.58 [dd, 2H, 4J(F−H) = 5.6, 3J(H−H) = 8.0, H2,6]; 7.19 [t, 2H, 3J(H−F) = 3J(H−H) = 8.4, 394 
H3,5]; 4.04 [t, 2H, 3J(H−H) = 6.0, CH2N]; 3.13 [s, 6H, NMe2]; 2.69 [t, 2H, 3J(H−H) = 6.0, H7]. 19F-395 
NMR (376,5 MHz, CDCl3): δ −104.40 [m]. ESI (+)-MS: 478.06 [M + NH4]+ ; 483.02 [M + Na]+. 396 
Anal. Found18 (calcd for C11H15Cl2FN2Pt): C, 28.5 (28.71); H, 3.1 (3.29); N, 6.1 (6.10). 397 
[PtCl2{Me2N(CH2)3N=CH(2,3,4-F3C6H)}] (2g). This compound was prepared by following the same 398 
procedure from 0.319 g (0.71 mmol) of cis-[PtCl2(dmso)2] and 0.173 g (0.71 mmol) of imine 1g. Yield 399 
(offwhite solid; mixture of E and Z isomers): 0.265 g (73%). 1H NMR (400 MHz, CDCl3): Z isomer δ 400 
10.75 [m, 1H]; 9.04 [s, 1H, 3J(Pt−H) = 120.0, CHN]; 7.29 [m, 1H]; {5.00 [m, 1H]; 4.26 [ddd, 1H, 401 
J(H−H) = 11.2, 6.8, 2.0], CH2N}; {2.97 [s, 3H]; 2.86 [s, 3H], NMe2}; 2.73 [m, 2H,CH2NMe2]; {2.48 402 
[m, 1H]; 2.01 [m, 1H], CH2CH2CH2}. 1H NMR (400 MHz, CDCl3): E isomer δ 9.33 [s, 1H, 3J(Pt−H) 403 
= 56.0, CHN]; 7.18−7.14 [m, 2H]; 4.03 [t, 2H, 3J(H−H) = 6.8, CH2N]; 3.00 [s, 6H, NMe2]; 2.73 [m, 404 
2H, CH2NMe2]; 2.24 [m, 2H, CH2CH2CH2]. 19F NMR (376,5 MHz, CDCl3): Z isomer δ −122.53 [m, 405 
1F, F2]; − 135.92 [dddd, 1F, 3J(F−F) = 22.6, 4J(F−F) = 15.2, 3J(F−H) = 7.6, 3J(F−H) = 3.8, F4]; − 406 
158.97 [tdd, 1F, 3J(F−F) = 22.5, 4J(F−H) = 7.6, 5J(F−H) = 3.8, F3]. 19F NMR (376,5 MHz, CDCl3): E 407 
isomer: δ −125.98 [m, 1F]; − 130.76 [m, 1F]; − 157.03 [tdd, 1F, 3J(F−F) = 18.8, 4J(F−H) = 7.6, 408 
5J(F−H) = 3.8, F3]. ESI (+)-MS: 528.06 [M + NH4]+; 475.05 [M − Cl]. Anal. Found (calcd) for 409 
C12H15Cl2F3N2Pt: C, 28.0 (28.29); H, 3.0 (2.97); N, 5.7 (5.50). 410 
[PtCl2{Me2N(CH2)2N=CH(2,3,4-F3C6H)}] (2h). This compound was prepared by following the same 411 
procedure from 0.300 g (0.71 mmol) of cis-[PtCl2(dmso)2] and 0.163 g (0.71 mmol) of imine 1h. Yield 412 
(yellow solid; E isomer): 0.250 g (71%). 1H NMR (400 MHz, CDCl3): δ 9.59 [s, 1H, 3J(Pt−H) = 48.0, 413 
CHN]; 7.34 [m, 1H]; 7.16 [m, 1H]; 3.87 [t, 2H, 3J(H−H) = 6.0, CH2N]; 3.13 [s, 6H, NMe2]; 2.71 [t, 2H, 414 
3J(H−H) = 6.0, H7]. 19F NMR (376,5 MHz, CDCl3): δ −125.34 [dddd, 1F, 3J(F−F) = 18.8, 4J(F−F) = 415 
15.0, 3J(F−H) = 7.5, 4J(F−H) = 3.8, F4]; − 128.91 [m, 1F, F2]; − 156.80 [tdd, 1F, 3J(F−F) = 18.8, 416 
4J(F−H) = 7.5, 5J(F−H) = 3.8, F3]. ESI (+)-MS: 514.04 [M + NH4]+. Anal. Found (calcd for 417 
C11H13Cl2F3N2Pt): C, 26.0 (26.66); H, 3.2 (2.65); N, 5.3 (5.66). 418 
[PtCl{Me2N(CH2)3N=CH(2-FC6H3)}] (3a). This compound was obtained using method 1: a mixture 419 
of 0.250 g (0.59 mmol) of cis-[PtCl2(dmso)2], 0.128 g (0.61 mmol) of imine 1a, and 0.050 g (0.61 420 
mmol) of sodium acetate in 20 mL of dry methanol was refluxed for 48 h. Upon evaporation of the 421 
solvent to 10 mL, small amounts of compound 2a and metallic platinum were filtered off, and the 422 
solution was kept at 5 °C until crystallization was completed. The solid was recrystallized in CH2Cl2/ 423 
MeOH to produce orange crystals. Yield: 22 mg (9%). Alternatively, compound 3a was prepared using 424 
method 2: a mixture of 0.150 g (0.316 mmol) of compound 2a and 0.026 g (0.316 mmol) of sodium 425 
acetate in 20 mL of dry methanol was heated under reflux for 48 h, and the solvent was evaporated to 426 
produce an oily residue that was extracted with 5 mL of CH2Cl2. Methanol was added, and the solution 427 
was kept at 5 °C until crystallization was completed. Yield (orange solid): 60 mg (43.3%). 1H NMR 428 
(400 MHz, CDCl3): δ 8.67 [t, 1H, 4J(H−H) = 1.6, 3J(Pt−H) = 142.4, CHN]; 7.80 [d, 1H, 3J(H−H) = 8.0, 429 
3J(H−Pt) = 40.0, H5]; 7.20 [m, 1H, H4]; 6.64 [ddd, 1H, 4J(H−H) = 0.8, 3J(H−H) = 8.0, 3J(F−H) = 10.0, 430 
H3]; 3.92 [m, 2H, NCH2]; 2.86 [m, 2H, CH2NMe2]; 2.85 [s, 6H, NMe2]; 2.04 [qi, 2H, 3J(H−H) = 5.2, 431 
CH2CH2CH2]. 19F NMR (376.5 MHz, CDCl3): δ − 115.00 [dd, 3J(F−H) = 9.8, 4J(F−H) = 6.0, 432 
4J(Pt−F) = 56.5]. ESI (+)-MS: 438.08 [M + H]+ ; 461.06 [M + Na]+. Anal. Found18 (calcd for 433 
C12H16ClFN2Pt): C, 33.1 (32.92); H, 3.7 (3.68); N, 6.1 (6.40). 434 
 435 
[PtCl{Me2N(CH2)3N=CH(4-FC6H3)}] (3b). This compound was prepared by following method 2 from 436 
0.150 g of 2b and an equimolar amount of sodium acetate. Yield (orange solid): 50 mg (36.0%). 1H 437 
NMR (400 MHz, CDCl3): δ 8.32 [t, 1H, 4J(H−H) = 1.6, 3J(Pt−H) = 141.6, CHN]; 7.72 [dd, 1H, 438 
3J(H−Pt) = 40.0, 3J(F−H) = 10.0, 4J(H− H) = 2.4, H5]; 7.24 [dd, 1H, 3J(H−H) = 8.0, 4J(H−F) = 4.0, 439 
H2]; 6.70 [td, 1H, 3J(F−H) = 3J(H−H) = 8.5, 4J(H−H) = 2.4, H3]; 3.86 [m, 3J(H−Pt) = 36.0, 2H, 440 
NCH2]; 2.85 [m, 8H, NMe2 + CH2NMe2]; 2.02 [qi, 2H, 3J(H−H) = 5.3, CH2CH2CH2]. 19F NMR 441 
(376.5 MHz, CDCl3): δ −104.07 [m, 1F]. 13C NMR (100.6 MHz, CDCl3): δ 27.23 [3J(C−Pt) = 31.0, 442 
CH2CH2CH2]; 50.19 [NMe2]; 57.50 [2J(C−Pt) = 38.0, NCH2]; 64.12 [CH2NMe2]; 110.37 [d, 2J(C−F) 443 
= 24.1, C3]; 121.17 [d, 2J(C−F) = 20.1, C5]; 129.01 [d, 3J(C−F) = 10.1, C2]; 141.00 [d, 4J(C−F) = 2.0, 444 
C1]; 146.00 [d, 3J(C−F) = 7.0, C6]; 163.54 [d, 1J(C−F) = 257.5, C4]; 175.13 [2J(C−Pt) = 96.6, CHN]. 445 
ESI (+)-MS: 439.07 [M + H]+ ; 456.10 [M + NH4]+ . Anal. Found18 (calcd for C12H16ClFN2Pt): C, 446 
32.0 (32.92); H, 3.7 (3.68); N, 6.3 (6.40). 447 
[PtCl{Me2N(CH2)2N=CH(2-FC6H3)}] (3c). This compound was prepared by following method 2 from 448 
0.150 g of 2c and an equimolar amount of sodium acetate and increasing the reaction time to 72 h. Yield 449 
(orange solid): 44 mg (32%). 1H NMR (400 MHz, CDCl3): δ 8.62 [t, 1H, 4J(H−H) = 1.2, 3J(Pt−H) = 450 
144.4, CHN]; 7.29 [m, 1H, H3]; 7.23 [t, 3J(H−H) = 7.8, 1H, H4]; 6.47 [d, 1H, 3J(H−H) = 8.1, H5]; 4.03 451 
[td, 2H, 3J(H−H) = 6.0, 4J(H−H) = 1.2, 3J(H−Pt) = 34.4, NCH2]; 3.10 [t, 2H, 3J(H−H) = 6.0, 452 
CH2NMe2]; 2.89 [s, 3J(H−Pt) = 14.8, 6H, NMe2]. 19F NMR (376.5 MHz, CDCl3): δ −108.14 [m, 1F]. 453 
ESI (+)-MS: 423.06 [M + H]+. Anal. Found18 (calcd for C11H14ClFN2Pt): C, 31.9 (31.20); H, 4.0 454 
(3.33); N, 6.1 (6.62). 455 
[PtCl{Me2N(CH2)2N=CH(4-FC6H3)}] (3d). This compound was prepared by following method 2 from 456 
0.150 g of 2d and the equimolar amount of sodium acetate and increasing the reaction time to 72 h. 457 
Yield (orange solid): 40 mg (29%). 1H NMR (400 MHz, CDCl3): δ 8.26 [s, 1H, 3J(Pt−H) = 141.2, 458 
CHN]; 7.41 [dd, 1H, 3J(F−H) = 9.5, 4J(H−H) = 2.8, 3J(H−Pt) = 50.8, H5]; 7.24 [dd, 1H, 3J(H−H) = 8.0, 459 
4J(H−F) = 5.6, H2]; 6.69 [td, 1H, 3J(F−H) = 3J(H−H) = 8.8, 4J(H−H) = 2.8, H3]; 4.06 [t, 2H, 3J(H−H) 460 
= 6.0, NCH2]; 3.11 [t, 2H, 3J(H−H) = 6.0, CH2NMe2]; 2.90 [s, 6H, NMe2]. 19F NMR (376.5 MHz, 461 
CDCl3): δ −102.92 [m, 1F]. ESI (+)-MS: 442.08 [M + NH4]+. Anal. Found (calcd for 462 
C11H14ClFN2Pt): C, 30.7 (31.20); H, 3.4 (3.33); N, 6.7 (6.62). 463 
[PtCl{Me2N(CH2)3N=CH(2-OMe,3,4-F2C6H)}] (3g). This compound was prepared following method 464 
2 from 0.150 g of 2g and an equimolar amount of sodium acetate and increasing the reaction time to 72 465 
h. Yield (orange solid): 40 mg (28%). 1H NMR (400 MHz, CDCl3): δ 8.59 [s, 1H, 3J(Pt−H) = 144.0, 466 
CHN]; 7.48 [dd, 1H, 3J(F−H) = 11.5, 4J(H−F) = 7.5, H5]; 4.01 [d, 3H, 5J(H−F) = 4.0, OMe]; 3.86 [t, 467 
2H, 3J(H−H) = 4.0, NCH2]; 2.83 [m, 8H, NMe2 + CH2NMe2]; 2.01 [m, 2H, CH2CH2CH2]. 19F NMR 468 
(376.5 MHz, CDCl3): δ −127.20 [dd, 1F, 3J(F−F) = 18.8, 3J(H−F) = 11.3, 4J(H−Pt) = 45.2, F4]; − 469 
163.15 [ddq, 1F, 3J(F−F) = 18.8, 4J(H−F) = 7.5, 5J(H−F) = 3.8, F3]. HRESI(+)- MS: m/z 486.0705, 470 
calcd for C13H18F2ClN2OPt [M + H]+ 486.0718; 450.0937, calcd for C13H17F2N2OPt [M − Cl]+ 471 
450.0951. Anal. Found (calcd for C13H17F2ClN2OPt): C, 31.7 (32.16); H, 3.5 (3.53); N, 5.6 (5.77). 472 
[PtCl{Me2N(CH2)2N=CH(2-OMe,3,4-F2C6H)}] (3h). This compound was prepared by following 473 
method 2 from 0.150 g of 2h and an equimolar amount of sodium acetate and increasing the reaction 474 
time to 72 h. Yield (orange solid): 42 mg (29%). 1H NMR (400 MHz, CDCl3): δ 8.56 [s, 1H, 3J(Pt−H) 475 
= 140.0, CHN]; 7.17 [dd, 1H, 3J(F−H) = 11.5, 4J(H−F) = 7.5, H5]; 4.06 [t, 2H, 3J(H−H) = 6.0, NCH2]; 476 
4.02 [d, 3H, 5J(H−F) = 3.2, OMe]; 3.01 [t, 2H, 3J(H−H) = 6.0, CH2NMe2]; 2.89 [s, 6H, 3J(Pt−H) = 477 
15.2, NMe2]. 19F NMR (376.5 MHz, CDCl3): δ −126.14 [dd, 1F, 3J(F−F) = 18.8, 3J(H−F) = 12.0, F4]; 478 
− 163.00 [ddq, 1F, 3J(F−F) = 18.8, 4J(H−F) = 7.5, 5J(H−F) = 3.8, F3]. ESI (+)-MS: 472.05 [M + H]+. 479 
Anal. Found (calcd for C12H15F2ClN2OPt): C, 30.4 (30.57); H, 3.4 (3.21); N, 5.8 (5.94). 480 
[PtMe{Me2N(CH2)3N=CH(2-FC6H3)}] (4a). This compound was obtained using the following 481 
procedure: 0.100 g (0.17 mmol) of [Pt2Me4(μ-SMe2)2] and 0.072 g (0.34 mmol) of imine 1a were 482 
dissolved in 20 mL of toluene, and the obtained solution was refluxed for 1 h. The solvent was removed, 483 
and the residue was treated with diethyl ether to give a red solid. Yield: 115 mg (79%). 1H NMR (400 484 
MHz, CDCl3): δ 8.91 [s, 1H, 3J(Pt−H) = 60.4, CHN]; 7.44 [d, 1H, 3J(Pt−H) = 64.0, 3J(H−H) = 8.0, 485 
H5]; 7.17 [td, 1H, 3J(H−H) = 8.0, 4J(H−F) = 6.4, H4]; 6.61 [ddd, 1H, 3J(F−H) = 10.4, 3J(H−H) = 8.0, 486 
4J(H−H) = 0.8, H3]; 3.89 [m, 2H, NCH2]; 2.91 [m, 2H, CH2NMe2]; 2.73 [s, 6H, 3J(Pt−H) = 24.0, 487 
NMe2]; 2.03 [qi, 2H, 3J(H−H) = 5.6, CH2CH2CH2]; 1.02 [s, 3H, 2J(Pt−H) = 80.0, Me-Pt]. 19F NMR 488 
(376.5 MHz, CDCl3): δ −117.53 [dd, 1F, 3J(F−H) = 11.3, 4J(F−H) = 7.5, 4J(Pt−F) = 56.5]. ESI (+)-MS: 489 
443.12 [M − H + CH3CN]+. Anal. Found (calcd for C13H19FN2Pt): C, 37.8 (37.41); H, 4.8 (4.59); N, 490 
6.3 (6.71). 491 
[PtMe{Me2N(CH2)3N=CH(4-FC6H3)}] (4b). This compound was obtained by using the same 492 
procedure from 0.100 g (0.17 mmol) of [Pt2Me4(μ-SMe2)2] and 0.078 g (0.35 mmol) of imine 1b. 493 
Yield (red solid): 105 mg (72%). 1H NMR (400 MHz, d6-acetone): δ 8.66 [s, 1H, 3J(Pt−H) = 62.8, 494 
CHN]; 7.32 [m, 1H, H2]; 7.21 [dd, 1H, 3J(H−F) = 11.2, 4J(H−H) = 2.5, 3J(Pt−H) = 35.6, H5]; 6.60 495 
[ddd, 1H, 3J(F−H) = 9.1, 3J(H−H) = 8.0, 4J(H−H) = 2.0, H3]; 3.85 [t, 2H, J(H−H) = 5.0, NCH2]; 2.87 496 
[m, 2H, CH2NMe2]; 2.66 [s, 6H, 3J(Pt−H) = 23.3, NMe2]; 1.99 [m, 2H, CH2CH2CH2]; 0.81 [s, 3H, 497 
2J(Pt−H) = 81.7, Me-Pt]. 19F-NMR (376.5 MHz, CDCl3): δ −107.58 [ddd, 1F, 3J(F−H) = 11.3, 498 
3J(F−H) = 7.5, 4J(F−H) = 3.7, 4J(F−Pt) = 71.5]. ESI (+)-MS: 443.12 [M − H + CH3CN]+. Anal. Found 499 
(calcd for C13H19FN2Pt·2H2O): C, 34.5 (34.44); H, 4.8 (5.11); N, 6.0 (6.17). 500 
[PtMe{Me2N(CH2)2N=CH(4-FC6H3)}] (4d). This compound was obtained by using the same 501 
procedure from 0.100 g (0.17 mmol) of [Pt2Me4(μ-SMe2)2] and 0.068 g (0.35 mmol) of imine 1d. 502 
Yield (red solid): 109 mg (77%). 1H NMR (400 MHz, d6-acetone): δ 8.71 [s, 1H, 3J(Pt−H) = 61.0, 503 
CHN]; 7.30 [dd, 3J(H−H) = 8.0, 4J(H−F) = 6.0, 4J(H−Pt) = 27.0, 1H, H2]; 7.10 [dd, 1H, 3J(H−F) = 504 
10.4, 4J(H−H) = 2.6, 3J(Pt−H) = 85.0, H5]; 6.57 [ddd, 1H, 3J(F−H) = 9.2, 3J(H−H) = 8.0, 4J(H−H) = 505 
2.6, H3]; 4.11 [t, 2H, 3J(H−H) = 6.0, NCH2]; 3.18 [t, 2H, 3J(H−H) = 6.0, CH2NMe2]; 2.77 [s, 6H, 506 
3J(Pt−H) = 21.0, NMe2]; 0.77 [s, 3H, 2J(Pt−H) = 79.0, Me-Pt]. 19F NMR (376.5 MHz, CDCl3): δ 507 
−106.64 [td, 1F, 3J(F−H) = 9.5, 4J(F−H) = 5.9, 4J(F−Pt) = 88.0]. ESI (+)-MS: 429.10 [M - H + 508 
CH3CN]+; 401.09 [M - Me + CH3CN]+. Anal. Found18 (calcd for C12H17FN2Pt): C, 34.5 (35.72); H, 509 
4.2 (4.25); N, 6.7 (6.95). 510 
[PtMe{Me2N(CH2)3N=CHC6H4}] (4e). This compound was obtained by using the same procedure 511 
from 0.100 g (0.17 mmol) of [Pt2Me4(μ-SMe2)2] and 0.065 g (0.35 mmol) of imine 1e. Yield (red 512 
solid): 95 mg (69%). 1H NMR (400 MHz, d6-acetone): δ 8.49 [s, 1H, 3J(Pt−H) = 60.0, CHN]; 7.61 [d, 513 
3J(H−H) = 7.6, 3J(H−Pt) = 64.0, 1H, H5]; 7.20 [m, 1H]; 7.07 [t, 1H, 3J(H−H) = 8.2, H4]; 6.88 [t, 1H, 514 
3J(H−H) = 7.4, H3]; 3.78 [t, 2H, 3J(H−H) = 4.8, NCH2]; 2.84 [m, 2H, CH2NMe2]; 2.66 [s, 6H, 515 
3J(Pt−H) = 22.4, NMe2]; 1.95 [qi, 2H, 3J(H−H) = 5.5, CH2CH2CH2]; 0.93 [s, 3H, 2J(Pt−H) = 81.0, 516 
Me-Pt]. ESI (+)-MS: 425.13 [M − H + CH3CN]+; 383.10 [M − Me]+. Anal. Found (calcd for 517 
C13H20N2Pt·H2O): C, 37.1 (37.41); H, 5.0 (5.31); N, 6.1 (6.71). 518 
[PtMe{Me2N(CH2)3N=CH(2,3,4-F3C6H)}] (4g). This compound was obtained by using the same 519 
procedure from 0.100 g (0.17 mmol) of [Pt2Me4(μ-SMe2)2] and 0.085 g (0.36 mmol) of imine 1g. 520 
Yield (red solid): 102 mg (65%). 1H NMR (400 MHz, d6-acetone): δ 8.85 [s, 1H, 3J(Pt−H) = 60.0, 521 
CHN]; 7.21 [ddd, 1H, 3J(H−F) = 9.0, 4J(H−F) = 7.2, 5J(H−F) = 2.0, H5]; 3.89 [t, 2H, J(H−H) = 4.0, 522 
NCH2]; 2.91 [m, 2H, CH2NMe2]; 2.73 [s, 6H, 3J(Pt−H) = 24.0, NMe2]; 2.03 [qi, 2H, 3J(H−H) = 5.5, 523 
CH2CH2CH2]; 0.95 [s, 3H, 2J(Pt−H) = 80.0, Me- Pt]. 19F NMR (376.5 MHz, CDCl3): δ −129.20 [ddd, 524 
1F, 3J(F−F) = 19.4, 3J(F−H) = 10.7, 4J(F−F) = 7.5, F4]; − 139.23 [dd, 1F, 3J(F−F) = 19.4, 4J(F−F) = 525 
7.5, F2]; − 170.41 [td, 1F, 3J(F−F) = 19.4, 4J(F−H) = 7.5, F3];. ESI (+)-MS: 437.07 [M − Me]+; 479.10 526 
[M − Me + CH3CN]+; 891.2 [2 M − Me]+. Anal. Found (calcd for C13H17F3N2Pt· H2O): C, 33.5 527 
(33.11); H, 4.1 (4.06); N, 5.8 (5.94). 528 
X-ray Diffraction. Suitable crystals were grown in dichloromethane−methanol at room temperature. X-529 
ray intensity data were measured on a D8 VENTURE system equipped with a multilayer 530 
monochromator and a Mo high brilliance microfocus source (λ = 0.71073 Å) at 100 K. For 3b, the 531 
integration of the data using a monoclinic unit cell yielded a total of 197137 reflections to a maximum θ 532 
angle of 25.11° (0.84 Å resolution), 18361 of which were independent and 16383 were greater than 533 
2σ(F2). Data were corrected for absorption effects using the multiscan method. For 3g, the integration of 534 
the data using a monoclinic unit cell yielded a total of 14556 reflections to a maximum θ angle of 30.54° 535 
(0.70 Å resolution), 3778 of which were independent and 3142 were greater than 2σ(F2). The structures 536 
were solved and refined using the Bruker SHELXTL software package.22 Further information is given 537 
in Table S1 (Supporting Information). 538 
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Legends to figures 630 
 631 
Scheme 1. Synthesis of Compounds 3 632 
 633 
Scheme 2. Synthesis of Compounds 3g,h with Fluoro for Methoxy Substitution 634 
 635 
Figure 1. Molecular structure of compound 3b (molecule a). Selected bond lengths (Å) and angles (deg) 636 
with estimated standard deviations: Pt(1a)−N(1a), 1.986(9); Pt(1a)−C(1a), 1.998(10); Pt(1a)−N(2a), 637 
2.174(8); Pt(1a)−Cl(1a), 2.297(3); N(2a)−C(10a), 1.483(15); C(10a)−C(9a), 1.53(2); C(9a)−C(8a), 638 
1.53(2); C(8a)−N(1a), 1.467(15); N(1a)−C(7a), 1.293(15); C(7a)−C(6a), 1.430(18); C(6a)−C(1a), 639 
1.383(15); N(2a)−Pt(1a)−N(1a), 97.2(4); N(1a)−Pt(1a)−C(1a), 80.3(4); C(1a)−Pt(1a)−Cl(1a), 93.1(3); 640 
N(2a)−Pt(1a)−Cl(1a), 89.5(3). 641 
 642 
Figure 2. Molecular structure of compound 3g. Selected bond lengths (Å) and angles (deg) with 643 
estimated standard deviations: Pt(1)−N(1), 1.997(4); Pt(1)−C(1), 2.000(3); Pt(1)−N(2), 2.174(3); 644 
Pt(1)−Cl(1), 2.3093(11); N(2)−C(10), 1.498(5); C(10)−C(9), 1.521(6); C(9)−C(8), 1.514(6); C(8)−N(1), 645 
1.483(5); N(1)−C(7), 1.301(5); C(7)−C(6), 1.442(6); C(6)−C(1), 1.408(6); N(2)−Pt(1)−N(1), 96.78(13); 646 
N(1)−Pt(1)−C(1), 80.76(15); C(1)−Pt(1)−Cl(1), 92.85(13); N(2)−Pt(1)−Cl(1), 89.61(10). 647 
 648 
Scheme 3. Synthesis of Compounds 4 649 
 650 
Figure 3. Absorption spectra of compounds 3 in dichloromethane solution at 298 K at 10−4 M 651 
concentration. 652 
 653 
Figure 4. Emission spectra of compounds 3 in dichloromethane solution at 298 K: λexc 388 (3a), 376 654 
(3b), 400 (3c), 391 (3d), 383 (3e), 391 (3f), 383 (3g), 391 nm (3h); concentration 10−4 M; three slits. 655 
Emission spectra are normalized with respect to the strongest recorded emission maximum for 656 
comparison purposes. 657 
 658 
Figure 5. Absorption spectra of compounds 4 in dichloromethane solution at 298 K at 10−4 M 659 
concentration. 660 
 661 
Figure 6. Emission spectra of compounds 4 in dichloromethane solution at 77 K: λexc 405 (4a), 390 662 
(4b), 415 (4c), 400 (4d), 400 (4e), 409 (4f), 402 (4g), 410 nm (4h); concentration 10−4 M; three slits. 663 
Emission spectra are normalized with respect to the strongest recorded emission maximum for 664 
comparison purposes. 665 
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Table 1. Absorption and Emission Properties of Cyclometalated Platinum Compounds 3 and 4 in 720 
CH2Cl2 Solution and in the Solid Statea 721 
 722 
 723 
 724 
